Scott Wexelblatt

Peer Reviewed Publications

Winhusen, Theresa; Lofwall, Michelle; Jones, Hendrée E; Wilder, Christine; Lindblad, Robert; Schiff, Davida M; Wexelblatt, Scott; Merhar, Stephanie; Murphy, Sean M; Greenfield, Shelly F; Terplan, Mishka; Wachman, Elisha M; Kropp, Frankie; Theobald, Jeff; Lewis, Mitra; Matthews, Abigail G; Guille, Connie; Silverstein, Michael; Rosa, Carmen (2020. ) Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.Contemporary clinical trials, , 93 ,106014 More Information

Rossi, Robert M; Wolfe, Christopher; Brokamp, Richard; McAllister, Jennifer M; Wexelblatt, Scott; Warshak, Carri R; Hall, Eric S (2020. ) Reported Prevalence of Maternal Hepatitis C Virus Infection in the United States.Obstetrics and gynecology, , 135 (2 ) ,387-395 More Information

Walsh, Michele C; Crowley, Moira; Wexelblatt, Scott; Ford, Susan; Kuhnell, Pierce; Kaplan, Heather C; McClead, Richard; Macaluso, Maurizio; Lannon, Carole (2018. ) Ohio Perinatal Quality Collaborative Improves Care of Neonatal Narcotic Abstinence Syndrome.Pediatrics, , 141 (4 ) , More Information

Hunter, Lisa L; Meinzen-Derr, Jareen; Wiley, Susan; Horvath, Carrie L; Kothari, Reena; Wexelblatt, Scott (2016. ) Influence of the WIC Program on Loss to Follow-up for Newborn Hearing Screening.Pediatrics, , 138 (1 ) , More Information

Percy Z.;Brokamp C.;McAllister J.M.;Ryan P.;Wexelblatt S.L.;Hall E.S. (07-01-2020. ) Subclinical and Overt Newborn Opioid Exposure: Prevalence and First-Year Healthcare Utilization.Journal of Pediatrics, , 222 ,52-58.e1 More Information

Protopapas S.;Murrison L.B.;Wexelblatt S.L.;Blackard J.T.;Hall E.S. (12-01-2019. ) Addressing the disease burden of vertically acquired hepatitis C virus infection among opioid-expose.Open Forum Infectious Diseases, , 6 (12 ) , More Information

Hall E.;McAllister J.;Wexelblatt S. (02-01-2019. ) Developmental Disorders and Medical Complications among Infants with Subclinical Intrauterine Opioid.Population Health Management, , 22 (1 ) ,19-24 More Information

Hall E.;Wexelblatt S.;Greenberg J. (12-01-2018. ) Surveillance of Intrauterine Opioid Exposures Using Electronic Health Records.Population Health Management, , 21 (6 ) ,486-492 More Information

Wexelblatt S.;McAllister J.;Nathan A.;Hall E. (06-01-2018. ) Opioid Neonatal Abstinence Syndrome: An Overview.Clinical Pharmacology and Therapeutics, , 103 (6 ) ,979-981 More Information

McAllister J.;Hall E.;Hertenstein G.;Merhar S.;Uebel P.;Wexelblatt S. (05-01-2018. ) Torticollis in Infants with a History of Neonatal Abstinence Syndrome.Journal of Pediatrics, , 196 ,305-308 More Information

Hall E.S.;Rice W.R.;Folger A.T.;Wexelblatt S.L. (03-01-2018. ) Comparison of Neonatal Abstinence Syndrome Treatment with Sublingual Buprenorphine versus Convention.American Journal of Perinatology, , 35 (4 ) ,405-412 More Information

Hall E.;Wexelblatt S.;Greenberg J. (10-01-2016. ) Self-reported and laboratory evaluation of late pregnancy nicotine exposure and drugs of abuse.Journal of Perinatology, , 36 (10 ) ,814-818 More Information

Goyal N.;Hall E.;Kahn R.;Wexelblatt S.;Greenberg J.;Samaan Z.;Brown C. (09-01-2016. ) Care Coordination Associated with Improved Timing of Newborn Primary Care Visits.Maternal and Child Health Journal, , 20 (9 ) ,1923-1932 More Information

Hall E.S.;Isemann B.T.;Wexelblatt S.L.;Meinzen-Derr J.;Wiles J.R.;Harvey S.;Akinbi H.T. (03-01-2016. ) A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.Journal of Pediatrics, , 170 ,39-44.e1 More Information

Hall E.;Meinzen-Derr J.;Wexelblatt S. (12-01-2015. ) Cohort Analysis of a Pharmacokinetic-Modeled Methadone Weaning Optimization for Neonatal Abstinence .The Journal of pediatrics, , 167 (6 ) ,1221-1225.e1 More Information

Wexelblatt S.;Ward L.;Torok K.;Tisdale E.;Meinzen-Derr J.;Greenberg J. (01-01-2015. ) Universal maternal drug testing in a high-prevalence region of prescription opiate abuse.Journal of Pediatrics, , 166 (3 ) ,582-586 More Information

Hall E.S.;Wexelblatt S.L.;Crowley M.;Grow J.L.;Jasin L.R.;Klebanoff M.A.;McClead R.E.;Meinzen-Derr J.;Mohan V.K.;Stein H.;Walsh M.C. (01-01-2015. ) Implementation of a neonatal abstinence syndrome weaning protocol: A multicenter cohort study.Pediatrics, , 136 (4 ) ,e803-e810 More Information

Winhusen T.;Wilder C.;Wexelblatt S.;Theobald J.;Hall E.;Lewis D.;Van Hook J.;Marcotte M. (08-23-2014. ) Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatm.Contemporary Clinical Trials, , 39 (1 ) ,158-165 More Information

Hall E.S.;Wexelblatt S.L.;Crowley M.;Grow J.L.;Jasin L.R.;Klebanoff M.A.;McClead R.E.;Meinzen-Derr J.;Mohan V.K.;Stein H.;Walsh M.C. (08-01-2014. ) A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.Pediatrics, , 134 (2 ) , More Information

Moyer L.;Goyal N.;Meinzen-Derr J.;Ward L.;Rust C.;Wexelblatt S.;Greenberg J. (01-01-2014. ) Factors associated with readmission in late-preterm infants: a matched case-control study.Hospital pediatrics, , 4 (5 ) ,298-304 More Information

Wexelblatt S.;Greenberg J.;Nathan A. (04-01-2010. ) Regional care model enables rapid response to adverse drug events.Journal of Perinatology, , 30 (4 ) ,300 More Information